Strong Quarterly Revenue; Positive Cash Flow; Backlog of $176 Million MADISON - TomoTherapy Incorporated, producer of the Hi·Art® treatment system for advanced radiation therapy, today released financial results for the fourth quarter ended December 31, 2008. Fourth Quarter Results The company reported fourth quarter 2008 revenue of $86.3...
The Wisconsin Biotechnology & Medical Device Association will now be BioForward. A move that according to Laura Strong, Ph.D., president of BioForward's board of directors, more accurately reflects the group's efforts to create investment and partnering opportunities, attract and retain the best talent, and...
Taking a chemical approach, researchers at the University of Wisconsin-Madison have developed a two-step method to convert the cellulose in raw biomass into a promising biofuel. The process, which is described in the Wednesday, Feb. 11 issue of the Journal of the American Chemical Society,...
MADISON, Wis.--Gentel Biosciences announces the promotion of G. Randall Durnell, Ph.D., to Executive Vice President & Chief Operating Officer and the hiring of Dan Clutter, Ph.D., as Vice President of Commercial Development. Dr. Durnell has been with Gentel for over a year where he served...
Columnist Michael Rosen states that although there was gloom in the overall VC landscape, one bright spot was the CleanTech, a relative newcomer to the categories of investment. CleanTech includes: alternative energy, pollution and recycling, power supplies, and conservation. In this edition of Yer Biotech...
Gentel Biosciences, a nine-year-old privately held protein-array firm based in Madison, Wis., is planning to launch assays for carbohydrate and protein biomarker profiling this month, and to debut a new high-throughput microarray platform called APiX in June, according to a company official. Dan Clutter, Gentel's new...
German scientists have sent mouse stem cells back to their embryonic origin by introducing just a single gene, a finding that could eventually lead to simpler, safer ways of generating cells for human medicine. A little more than a year ago, researchers in Madison and...
Madison, Wis. - Stratatech Corp., a privately-held regenerative medicine company, today announced that it has genetically modified its StrataGraft living human skin substitute to actively fight costly bacterial infections that routinely develop at the site of burns and other severe skin injuries, such as skin...
Milwaukee, Wis. - Prodesse, Inc. announced today that it has filed a submission with the U.S. Food and Drug Administration for 510(k) clearance to market its ProGastro Cd assay as an in vitro diagnostic product in the United States. Clinical trials were conducted at several...
Milwaukee, Wis. - Today's announcement by Wisconsin's largest ethanol producer, Renew Energy, LLC, that they have filed for Chapter 11 bankruptcy protection is a reflection on the harsh economic conditions facing a number of Wisconsin industries. “The harsh reality is that there aren't many, if any,...